Literature DB >> 1417582

Virulence factors of Escherichia coli associated with colisepticemia in chickens and turkeys.

D A Emery1, K V Nagaraja, D P Shaw, J A Newman, D G White.   

Abstract

Four hundred twenty turkey and 80 chicken Escherichia coli isolates from colisepticemic birds were examined for the following properties: heat-labile toxin (LT), heat-stable enterotoxin, verotoxin, colicinogenicity, hemolysin, and hydroxamate/aerobactin production. Twenty-four (5.7%) of the 420 turkey isolates and six (7.5%) of the 80 chicken isolates produced an LT that was cytotoxic for both Vero and Y-1 cells. In contrast, 48 (11.4%) of the turkey isolates and 18 (22.5%) of the chicken isolates produced a distinct LT that was cytotoxic only for Vero cells. In addition, 64 (80.0%) of the chicken isolates and 309 (74.0%) of the turkey isolates produced aerobactin. Colicinogenicity occurred in 51 (64.0%) of the chicken isolates, with 41 (51.0%) producing colicin V. By contrast, 254 (61.0%) of the turkey isolates produced a colicin, of which 176 (42.0%) produced colicin V. None of the chicken and turkey isolates produced hemolysin or heat-stable enterotoxin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417582

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  11 in total

1.  Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli.

Authors:  D G White; L J Piddock; J J Maurer; S Zhao; V Ricci; S G Thayer
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region.

Authors:  C M Dozois; M Dho-Moulin; A Brée; J M Fairbrother; C Desautels; R Curtiss
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Colonization of the respiratory tract by a virulent strain of avian Escherichia coli requires carriage of a conjugative plasmid.

Authors:  C A Ginns; M L Benham; L M Adams; K G Whithear; K A Bettelheim; B S Crabb; G F Browning
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Production of toxins (enterotoxins, verotoxins, and necrotoxins) and colicins by Escherichia coli strains isolated from septicemic and healthy chickens: relationship with in vivo pathogenicity.

Authors:  J E Blanco; M Blanco; A Mora; J Blanco
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 5.  Avian colibacillosis and salmonellosis: a closer look at epidemiology, pathogenesis, diagnosis, control and public health concerns.

Authors:  S M Lutful Kabir
Journal:  Int J Environ Res Public Health       Date:  2010-01-12       Impact factor: 3.390

6.  Characterization of Escherichia coli isolates incriminated in colisepticaemia in mink.

Authors:  R J Tibbetts; D G White; N W Dyer; C W Giddings; L K Nolan
Journal:  Vet Res Commun       Date:  2003-07       Impact factor: 2.459

7.  A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys.

Authors:  J K Kwaga; B J Allan; J V van der Hurk; H Seida; A A Potter
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

8.  Phenotypic and genotypic analysis of pathogenic Escherichia coli virulence genes recovered from Riyadh, Saudi Arabia.

Authors:  Abdullah A Al-Arfaj; Mohamed S Ali; Ashgan M Hessain; Adel M Zakri; Turki M Dawoud; Khalid S Al-Maary; Ihab M Moussa
Journal:  Saudi J Biol Sci       Date:  2015-11-24       Impact factor: 4.219

9.  An evaluation of the virulence and adherence properties of avian pathogenic Escherichia coli.

Authors:  Kyle LeStrange; Sarah M Markland; Dallas G Hoover; Manan Sharma; Kalmia E Kniel
Journal:  One Health       Date:  2017-08-21

10.  LT-IIc, a new member of the type II heat-labile enterotoxin family encoded by an Escherichia coli strain obtained from a nonmammalian host.

Authors:  Hesham F Nawar; Natalie D King-Lyons; John C Hu; Raymond C Pasek; Terry D Connell
Journal:  Infect Immun       Date:  2010-08-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.